FDA inspection
Cardinal Health Manufacturing Services B.V.: FDA inspection ending May 27, 2004
FDA inspection 328883 · Voluntary Action Indicated (VAI) · Humacao, PR
Key facts
| Inspection ID | 328883 |
|---|---|
| Firm | Cardinal Health Manufacturing Services B.V. |
| FEI number | 2650094 |
| Address | Rd 925 Km. 6.1 |
| City | Humacao |
| State | PR |
| ZIP | 00792 |
| Fiscal year | 2004 |
| Inspection end date | May 27, 2004 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Compliance: Med Devices|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation |
| Product type | Devices, Drugs |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data